Clinical Trials
2 trialsNCT02617277 2026-03-04
Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT05508334 2025-12-22
A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours
RemeGen Co., Ltd.
Phase 1/2 Completed